These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36455375)

  • 1. A biosensing system employing nonlinear dynamic analysis-assisted neural network for drug-induced cardiotoxicity assessment.
    Yang W; Ouyang Q; Zhu Z; Wu Y; Fan M; Liao Y; Guo X; Xu Z; Zhang X; Zhang Y; Hu N; Zhang D
    Biosens Bioelectron; 2023 Feb; 222():114923. PubMed ID: 36455375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-labeled neural network model for automatically processing cardiomyocyte mechanical beating signals in drug assessment.
    Ouyang Q; Yang W; Wu Y; Xu Z; Hu Y; Hu N; Zhang D
    Biosens Bioelectron; 2022 Aug; 209():114261. PubMed ID: 35429771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating nonlinear analysis and machine learning for human induced pluripotent stem cell-based drug cardiotoxicity testing.
    Kowalczewski A; Sakolish C; Hoang P; Liu X; Jacquir S; Rusyn I; Ma Z
    J Tissue Eng Regen Med; 2022 Aug; 16(8):732-743. PubMed ID: 35621199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electromechanical integrated recording of single cardiomyocyte in situ by multimodal microelectrode biosensing system.
    Zhang D; Xiang Y; Zou Q; Zhu K; Hu N
    Biosens Bioelectron; 2022 Sep; 212():114387. PubMed ID: 35635972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal and Sensitive Drug Assessment Biosensing Platform Using Optimal Mechanical Beating Detection of Single Cardiomyocyte.
    Xu D; Xiao H; Wang S; Li H; Chen HJ; Liu C; Hu N
    ACS Nano; 2022 Sep; 16(9):15484-15494. PubMed ID: 36094397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid Integrated Cardiomyocyte Biosensors for Bitter Detection and Cardiotoxicity Assessment.
    Wei X; Jiang D; Chen C; Wu J; Qin C; Yuan Q; Xue Y; Xiong Y; Zhuang L; Hu N; Wang P
    ACS Sens; 2021 Jul; 6(7):2593-2604. PubMed ID: 34253023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity.
    Sirenko O; Cromwell EF; Crittenden C; Wignall JA; Wright FA; Rusyn I
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):500-7. PubMed ID: 24095675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biosensing system using a multiparameter nonlinear dynamic analysis of cardiomyocyte beating for drug-induced arrhythmia recognition.
    Wang H; Wu Y; Zou Q; Yang W; Xu Z; Dong H; Zhu Z; Wang D; Wang T; Hu N; Zhang D
    Microsyst Nanoeng; 2022; 8():49. PubMed ID: 35547605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes.
    Cao L; der Meer ADV; Verbeek FJ; Passier R
    BMC Bioinformatics; 2020 May; 21(1):187. PubMed ID: 32408861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro models of stem cell-derived cardiomyocytes to screen for potential cardiotoxicity of chemicals.
    Shi M; Tien NT; de Haan L; Louisse J; Rietjens IMCM; Bouwmeester H
    Toxicol In Vitro; 2020 Sep; 67():104891. PubMed ID: 32446838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes.
    Chaudhari U; Nemade H; Sureshkumar P; Vinken M; Ates G; Rogiers V; Hescheler J; Hengstler JG; Sachinidis A
    Arch Toxicol; 2018 Jan; 92(1):371-381. PubMed ID: 28940058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
    Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
    Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEA-integrated cantilever platform for comparison of real-time change in electrophysiology and contractility of cardiomyocytes to drugs.
    Kanade PP; Oyunbaatar NE; Shanmugasundaram A; Jeong YJ; Kim ES; Lee BK; Lee DW
    Biosens Bioelectron; 2022 Nov; 216():114675. PubMed ID: 36070668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition.
    Hu N; Wang T; Wang Q; Zhou J; Zou L; Su K; Wu J; Wang P
    Biosens Bioelectron; 2015 May; 67():146-53. PubMed ID: 25153933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes.
    Jans D; Callewaert G; Krylychkina O; Hoffman L; Gullo F; Prodanov D; Braeken D
    J Pharmacol Toxicol Methods; 2017 Sep; 87():48-52. PubMed ID: 28549786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization.
    Burnett SD; Blanchette AD; Chiu WA; Rusyn I
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):887-902. PubMed ID: 33612039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.